| Literature DB >> 32180771 |
Fany Blanc1,2,3, Armelle Prévost-Blondel1,4,5, Guillaume Piton2,3, Edwige Bouguyon6, Jean-Jacques Leplat2,3, Fabrice Andréoletti2,3, Giorgia Egidy2, Emmanuelle Bourneuf2,3,7, Nicolas Bertho6,8, Silvia Vincent-Naulleau2,3.
Abstract
Immunological research in pigs benefits from many improvements with a direct impact on the veterinary control of pig husbandry and on biomedical models. We compiled the available knowledge to develop gating strategies to monitor simultaneously all blood immune cell types by multicolor flow cytometry in Melanoblastoma-bearing Libechov Minipigs (MeLiM). The MeLiM pig spontaneously develops cutaneous melanomas that regress few months later. We monitored lymphoid and myeloid cell subsets in 3 to 21 weeks old pigs. Interestingly, neutrophils, type III monocytes (CD163+ CD14+ MHC II-) and CD4- CD8α- T cells are less abundant in oldest animals in contrast to eosinophils, type II monocytes (CD163- CD14low MHC II+), B cells, γδ T cells, CD4+ CD8α+ and CD4- CD8α+ T cells. Melanoma occurrence led to changes in the blood cell composition. Higher proportions of NK cells, CD4+ and CD4+ CD8α+ T cells, and CD21- B cells among B cells are found in young melanoma-bearing piglets, consistent with the immune-mediated spontaneous regression in the MeLiM model.Entities:
Keywords: age; biomedical model; longitudinal analysis; lymphoid cells; melanoma; myeloid cells; swine blood leucocytes
Mesh:
Substances:
Year: 2020 PMID: 32180771 PMCID: PMC7059855 DOI: 10.3389/fimmu.2020.00291
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Number of pigs sampled for each group of age, with their sex, melanoma occurrence, presence of palpable lymphadenopathies, and tumor burden.
| All animals ( | 22 | 14 | 32 | 14 | 22 | 26 | 16 | 15 | 161 |
| Males ( | 10 | 4 | 13 | 6 | 10 | 8 | 5 | 6 | 62 |
| Females ( | 12 | 10 | 19 | 8 | 12 | 18 | 11 | 9 | 99 |
| Healthy pigs ( | 7 | 1 | 7 | 3 | 5 | 2 | 2 | 2 | 29 |
| Melanoma-bearing pigs ( | 15 | 13 | 25 | 11 | 17 | 24 | 14 | 13 | 132 |
| With palpable lymphadenopathies | 3 | 10 | 21 | 9 | 11 | 21 | 11 | 10 | 96 |
| With high tumor burden | 8 | 10 | 18 | 6 | 9 | 20 | 10 | 10 | 91 |
Antibodies used in this study.
| CD45 | K252- 1E4 | m IgG1 | p | AF647 | Directly conjugated | 1 | 1/20 | A, B, C, D, E |
| CD3 | PPT3 | m IgG1 | p | FITC | Directly conjugated | 2 | 2.5 μg/mL | A, B |
| CD8alpha | 76-2-11 | m IgG2a | p | PE-Cy5 | Directly conjugated | 3 | 1 μg/mL | A, B |
| CD4 | 74-12-4 | m IgG2b | p | APC-Cy7 | Secondary antibody | 3 | 2.5 μg/mL | A, B |
| γδTCR | PGBL22A | m IgG1 | p | PE-Cy7 | Secondary antibody | 4 | 2 μg/mL | A |
| CD16 | G7 | m IgG1 | p | PE | Directly conjugated | 1 | 1/20 | A |
| CD25 | K231.3B2 | m IgG1 | p | PE-Cy7 | Secondary antibody | 1 | 1/10 | B |
| Foxp3* | FJK-16s | r IgG2a | m/r | PE | Directly conjugated | 5 | 1/50 | B |
| control | eBR2a | r IgG2a | PE | Directly conjugated | 5 | 1/50 | B | |
| MHC II | MSA3 | m IgG2a | p | AF488 | Secondary antibody | 4 | 2 μg/mL | C, D |
| CD21 | B-Ly4 | m IgG1 | h | PE-Cy7 | Secondary antibody | 6 | 4 μg/mL | C |
| CD79a* | HM57 | m IgG1 | h | PE | Directly conjugated | 1 | 50 μg/mL | C |
| control | MOPC-21 | m IgG1 | PE | Directly conjugated | 7 | 1/20 | C | |
| PG68A | PG68A | m IgG1 | p | PE-Cy7 | Secondary antibody | 4 | 5 μg/mL | D |
| CD163 | HM57 | m IgG1 | p | PE | Directly conjugated | 1 | 1/10 | D, E |
| CD172a | 74-22-15A | m IgG2b | p | APC-Cy7 | Secondary antibody | 4 | 1 μg/mL | D, E |
| CD14 | TUK4 | m IgG2a | h | Pacific Blue | Directly conjugated | 1 | 1/10 | D |
| CADM1 | 3E1 | c IgY | h/m | Qdot655 | Secondary antibody | 8 | 4 μg/mL | D |
| CD14 | TUK4 | m IgG2a | h | AF488 | Biotin-streptavidin | 1 | 1/20 | E |
| MHC II | MSA3 | m IgG2a | p | PerCp-eFluor710 | Secondary antibody | 4 | 2 μg/mL | E |
A, B, C, and D correspond to the four antibodies combinations to identify cell subsets: A for lymphocyte subsets, B for Tregs, C for B lymphocytes, and D for myeloid cells (*intracellular stainings). Combination E was used to analyze monocytes by imaging flow cytometry. (1: AbD Serotec, 2: SouthernBiotech, 3: Abcam, 4: WSU, 5: eBioscience, 6: BD Biosciences, 7: Exbio, 8:MBL, c: chicken, h: human, m: mouse, p: pig, r: rat).
Goat anti-mouse IgG2b-APC-Cy7, 1.25 μg/mL, Abcam.
Goat anti-mouse IgG1-PE-Cy7, 0.5 μg/mL, eBioscience.
Goat anti-mouse IgG2a-AF488, 5 μg/mL, Invitrogen.
Goat anti-mouse IgG2a-PerCp-eFluor710, 0.5 μg/mL, eBioscience.
Streptavidin-AF488, 5 μg/mL, Invitrogen.
Goat anti-chicken IgY-Qdot655, 2.5nM, Exbio.
Absolute numbers and proportions of lymphocytes, monocytes and granulocytes in pig blood, and effect of age, sex, and melanoma occurrence on those phenotypes.
| 13.8 | 6.2 | 12.8 | 14.8 | 106 cells / mm3 | 0.824 | 0.470 | ||
| 4.8 | 2.1 | 4.5 | 5.1 | 106 cells / mm3 | 0.999 | |||
| (FSClow SSClow) | 36.9 | 11 | 35.2 | 38.6 | % of PBLs | 0.614 | ||
| 1.7 | 1 | 1.6 | 1.9 | 106 cells / mm3 | 0.406 | 0.528 | ||
| (FSCmed SSCmed) | 12.1 | 2.8 | 11.7 | 12.6 | % of PBLs | 0.208 | 0.998 | |
| 7.3 | 4.5 | 6.6 | 8 | 106 cells / mm3 | 0.444 | 0.853 | ||
| (FSCmed SSChigh) | 51.0 | 10.9 | 49.3 | 52.7 | % of PBLs | 0.160 | ||
Means, SD and 95% CI of mean obtained for the 36 pigs sampled from 3 to 21 weeks (n = 161) of lymphocytes, monocytes and granulocytes subpopulations gated basically by their size and morphology properties (being FSC.
Figure 1Identification and quantification of lymphocytes, monocytes and granulocytes in swine peripheral blood. (A) Illustrative dot plots showing the gating strategy used to identify PBLs subsets. Cells were first gated on FSC-A vs. SSC-A dot plot (upper left panel) and doublets were excluded on FSC-H vs. FSC-W dot plot (“singlets-1,” upper middle panel) and SSC-H vs. SSC-W dot plot (“singlets-2,” upper right panel). Dead cells were then excluded using live/dead staining (lower right panel). Immune cells were stained for CD45 (lower middle panel). Lymphocytes, monocytes, and granulocytes subpopulations from CD45+ cells were finally gated using size and morphology properties (lower left panel). Percentages of the parent populations are shown on each dot plot representing 10,000 events. (B) Absolute leukocyte count in blood according to pigs' age. Lines represent the means with SEM. Significant differences within groups of age are represented with bars (*p < 0.05). (C) Lymphocytes, monocytes and granulocytes distribution according to pigs' age. Different letters inside the bar plots indicate significant differences within groups of age for the corresponding cell population (p < 0.05).
Figure 2Kinetics of percentages of γδ T, CD4− CD8α−, CD4− CD8α+ T, CD4+ CD8α+ T, and NKT lymphocytes in swine peripheral blood. Lines represent the means with SEM. Significant differences are represented with bars (*p < 0.05, **p < 0.01, and ***p < 0.001).
Figure 3B cells in swine peripheral blood. (A) Gating strategy to identify B cells in PBLs. B cells were identified as CD79a+ among the CD45+ population described in Figure 1A (upper panel). A representative dot plot with CD79a isotype control (mouse IgG1) is shown (lower panel). CD21 and MHC II expression of B cells were studied (middle panel). Percentages of the parent populations are shown on each dot plot representing 10,000 events. Kinetics of the percentages of (B) B cells in PBLs and (C) CD21 and MHC II expressions among B cells. (D) Kinetics of total IgGs in sera assessed by ELISA. Lines represent the means with SEM. Significant differences within groups of age are represented with bars (*p < 0.05, **p < 0.01, and ***p < 0.001) or with different letters inside the bar plots of the corresponding population (p < 0.05).
Figure 4DCs and monocytes in swine peripheral blood. (A) Gating strategy to identify cDC1, cDC2 and monocytes in PBLs. Cells were first gated on the monocyte cell population described in Figure 1A. Within monocytes, MHC IIhigh were selected (upper left panel) and CD14−/low CD163−/low were gated (upper middle panel) and plotted on CADM1 vs. CD172a (upper right panel). cDC1 and cDC2 were gated as CADM1high CD172alow and CADM1low CD172ahigh, respectively. A Boolean gate was then created to get all the monocytes excluding only cDC1 and cDC2. Cells were then separated in CD163+ and CD163− (lower left panel) and MHC II and CD14 expressions were evaluated within those cell subsets. Within CD163− monocytes (lower middle panel), type I (CD163− CD14+ MHC II−) and type II (CD163− CD14low MHC II+) were identified and within CD163+ monocytes (lower right panel), type III (CD163+ CD14+ MHC II−) and type IV (CD163+ CD14low MHC II+). Percentages of the parent populations are shown on each dot plot representing 10,000 events. (B) Kinetics of percentages of cDC1 and cDC2 in peripheral blood. Lines represent the means with SEM. Different letters inside the bar plots indicate significant differences within groups of age for the corresponding cell population (p < 0.05). (C) Per cell nuclear and cytoplasmic areas and N/C ratios (nuclear divided by cytoplasmic area) of the monocyte subsets assessed by imaging flow cytometry. Lines link data from the same animals. Statistical analysis was performed using a Friedman test for non-parametric repeated values followed by Dunn's post test to compare the different monocyte subsets. Significant differences within monocyte subsets are represented with bars (**p < 0.01) or with different letters inside the bar plots of the corresponding population (p < 0.05). Letters above the bar plots indicate the significant differences for the total cell area. Kinetics of percentages of (D) CD163− and (E) CD163+ monocytes subsets in peripheral blood. Lines represent the means with SEM. Different letters inside the bar plots indicate significant differences within groups of age for the corresponding population (p < 0.05), letters above indicate the significant differences within groups of age for all the CD163− or CD163+ monocytes (p < 0.05).
Figure 5Granulocytes in swine peripheral blood. (A) Gating strategy to identify granulocytes in PBLs. Cells were first gated on the granulocyte population described in Figure 1A. PG68A−/low and PG68A+ cells were identified. Percentages of the parent populations are shown on each dot plot representing 10,000 events. (B) Microscopic images (MGG staining, × 40 original magnification or × 100 in the insert) of sorted PG68A+ and PG68A−/low cells. Images are representative of 3 independent sortings performed on 15 to 21 week-old pig granulocytes. Kinetics of percentages of (C) neutrophils and (D) eosinophils in peripheral blood. Lines represent the means with SEM. Significant differences are represented with bars (*p < 0.05, **p < 0.01, and ***p < 0.001).
Figure 6Effect of melanoma occurrence on immune blood cell composition of MeLiM pigs. (A) Blood cell proportions that differ between healthy and melanoma-bearing pigs aged of 3–4, 7–8, and 11–12 weeks. Proportions (B) of B cells CD21− MHC II+ among B cells and (C) of γδ T cells expressing CD8α among γδ T cells from healthy and melanoma-bearing pigs aged of 3–4, 7–8, and 11–12 weeks. Healthy and melanoma-bearing pigs at each age were compared using a Mann-Whitney test and significant differences are represented with bars (*p < 0.05 and **p < 0.01). (D) Kinetics of proportions of NK cells and γδ T cells in blood leukocytes depending on the presence of palpable lymphadenopathies and tumor burden in melanoma-bearing pigs (means with SEM). Groups of pigs at each age were compared using a Mann-Whitney test and significant differences are represented above (p < 0.1 and *p < 0.05).
Figure 7Models of the effects of age and melanoma occurrence on immune blood cell composition of MeLiM pigs. (A) Evolution of blood cell populations with age and (B) effect of melanoma on blood cell populations.